参考文献/References:
[1] Yau JW,Rogers SL,Kawasaki R,et al. Global prevalence and major risk factors of diabetic retinopathy[J].Diabetes Care,2012,35(3):556-564. DOI: 10.2337/dc11-1909.
[2] Liu L,Wu X,Liu L,et al. Prevalence of diabetic retinopathy in mainland China: a meta-analysis[J].PLoS One,2012,7(9):e45264. DOI:10.1371/journal.pone.0045264.
[3] Mahendra JV,Kumar SD,Anuradha TS,et al. Plasma fibrinogen in type 2 diabetic patients with metabolic syndrome and its relation with ischemic heart disease(IHD)and retinopathy[J].J Clin Diagn Res,2015,9(1):BC18-BC21. DOI: 10.7860/JCDR/2015/10712.5449.
[4] Wilkinson CP,Ferris FL 3rd,Klein RE,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1677-1682.
[5] Du ZD, Hu LT, Zhao GQ,et al. Epidemiological characteristics and risk factors of diabetic retinopathy in type 2 diabetes mellitus in Shandong Peninsula of China[J].Int J Ophthalmol,2011,4(2):202-206. DOI:10.3980/j.issn.2222-3959.2011.02.20.
[6] 何媛, 于德民, 周赛君, 等. 糖尿病视网膜病变的相关危险因素分析[J].中华糖尿病杂志,2012, 4(10):601-606. DOI:10.3760/cma.j.issn.1674-5809.2012.10.006.
[7] Ross R,Beck AW. Fibrinogen and catheter-directed thrombolysis[J].Semin Vasc Surg,2014,27(3-4):182-195. DOI:10.1053/j.semvascsurg.2015.04.003.
[8] Sarangi R, Padhi S, Mohapatra S,et al. Serum high sensitivity C-reactive protein, nitric oxide metabolites, plasma fibrinogen, and lipid parameters inIndian type 2 diabetic males[J].Diabetes Metab Syndr,2012,6(1):9-14.DOI:10.1016/j.dsx.2012.05.015.
[9] Xiong WX, Shen Y, Dai DP,et al. Clinical utility of the ratio between circulating fibrinogen and fibrin(ogen)degradation products for evaluatingcoronary artery disease in type 2 diabetic patients[J].Chin Med J(Engl),2015,128(6):727-732. DOI:10.4103/0366-6999.152465.
[10] 张志辉. 血小板参数、纤维蛋白原和D-二聚体在2型糖尿病微血管病变患者中的水平及意义[J]. 中国医药导报, 2014, 16:70-73.
[11] 王欣荣, 于敬妮, 李辉. 血小板分布宽度及纤维蛋白原与DR严重程度的关系[J]. 国际眼科杂志,2015,04:643-645.DOI:10.3980/j.issn.1672-5123.2015.4.19.
[12] Azad N,Agrawal L,Emanuele NV,et al. Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial(VADT)[J].Diabetes Care,2014,37(2):501-506.DOI:10.2337/dc13-1193.
[13] 王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J]. 国际内分泌代谢杂志, 2015,35(3):153-157.DOI:10.3760/cma.j.issn.1673-4157.2015.03.003.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍:2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(01):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(01):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(01):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(01):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
[11]张伊桐,佟雪巍,徐宇欣,等.2型糖尿病患者静息代谢率与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2023,43(06):464.[doi:10.3760/cma.j.cn121383-20220724-07049]
Zhang Yitong,Tong Xuewei,Xu Yuxin,et al.Relationship between resting metabolic rate and diabetic retinopathy in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2023,43(01):464.[doi:10.3760/cma.j.cn121383-20220724-07049]